Does smoking impact dopamine neuronal loss in de novo Parkinson disease?
- 31 October 2017
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 82 (5) , 850-854
Abstract
This study analyzed data from dopamine transporter (DAT) positron emission tomographic scans of 282 male patients with de novo Parkinson disease to investigate whether smoking impacts striatal dopamine neuronal degeneration. Mean DAT activity in the posterior (p = 0.016) and ventral putamen (p = 0.028) was higher in 44 current smokers in comparison to 105 ex‐smokers and 133 never‐smokers. The severity of baseline motor deficits and the longitudinal increases in levodopa‐equivalent doses during follow‐up were similar among the 3 groups. These results suggest that current smoking, but not past smoking, protects dopamine neuronal degeneration in the sensorimotor striatum with no additional clinical benefits. Ann Neurol 2017;82:850–854Keywords
This publication has 20 references indexed in Scilit:
- Is normosmic Parkinson disease a unique clinical phenotype?Neurology, 2015
- Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System AtrophyJournal of Nuclear Medicine, 2012
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Smoking and Parkinson's disease: Systematic review of prospective studiesMovement Disorders, 2004
- Parkinson’s Disease Protects Against Smoking?Behavioural Neurology, 2004
- Smoking and Parkinson’s diseaseNeurology, 1999
- Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loopBrain Research Reviews, 1995
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatmentNeuroscience Letters, 1991
- Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smokeNeuropharmacology, 1990
- The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988